Table 2 Baseline medications
SGLT2i (n = 22) | Control (n = 20) | p-value | |
|---|---|---|---|
Insulin | 9 (40.9%) | 5 (25%) | 0.27 |
Metformin | 20 (90.9%) | 18 (90%) | 0.92 |
Sulfonylurea | 5 (22.7%) | 9 (45%) | 0.12 |
DPP-4 inhibitor | 0 (0%) | 1 (5%) | 0.28 |
Glitazone | 0 (0%) | 0 (0%) | – |
Oral anticoagulant | 4 (18.2%) | 1 (5%) | 0.18 |
Statin | 21 (95.5%) | 20 (100%) | 0.33 |
Beta-blocker | 19 (86.4%) | 16 (80%) | 0.58 |
Angiotensin II receptor blocker | 4 (18.2%) | 9 (45%) | 0.06 |
ACE inhibitors | 15 (68.2%) | 9 (45%) | 0.12 |